These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16771094)

  • 61. Seronegative spondyloarthropathies and diffuse idiopathic skeletal hyperostosis in ancient northern Chile.
    Arriaza BT
    Am J Phys Anthropol; 1993 Jul; 91(3):263-78. PubMed ID: 8333484
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vertebral hyperostosis and diabetes mellitus: a case-control study.
    Daragon A; Mejjad O; Czernichow P; Louvel JP; Vittecoq O; Durr A; Le Loët X
    Ann Rheum Dis; 1995 May; 54(5):375-8. PubMed ID: 7794043
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus.
    Sencan D; Elden H; Nacitarhan V; Sencan M; Kaptanoglu E
    Rheumatol Int; 2005 Sep; 25(7):518-21. PubMed ID: 16167164
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The heel in systemic disease.
    Lichniak JE
    Clin Podiatr Med Surg; 1990 Apr; 7(2):225-41. PubMed ID: 2189535
    [TBL] [Abstract][Full Text] [Related]  

  • 65. DISH ... a state not a disease?
    Hutton C
    Br J Rheumatol; 1989 Aug; 28(4):277-8. PubMed ID: 2525941
    [No Abstract]   [Full Text] [Related]  

  • 66. Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: back to square one.
    Mader R; Buskila D; Verlaan JJ; Atzeni F; Olivieri I; Pappone N; Di Girolamo C; Sarzi-Puttini P
    Rheumatology (Oxford); 2013 Feb; 52(2):326-30. PubMed ID: 23024057
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impaired osteophyte formation and ankylosing hyperostosis in patients with diabetes: comment on the article by Horn et al.
    Pal B
    Arthritis Rheum; 1993 Feb; 36(2):287-8. PubMed ID: 8431225
    [No Abstract]   [Full Text] [Related]  

  • 68. [Overview: derangement of bone metabolism in diabetes mellitus].
    Takeuchi Y
    Clin Calcium; 2009 Sep; 19(9):1247-55. PubMed ID: 19721195
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diffuse idiopathic skeletal hyperostosis with prominent appendicular bone proliferation in a dog.
    Oh J; Lee JH; Cho KO; Choi J
    J Vet Med Sci; 2015 Apr; 77(4):493-7. PubMed ID: 25648674
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Involvement of insulin-like growth factor-I in the control of glucose homeostasis.
    Clemmons DR
    Curr Opin Pharmacol; 2006 Dec; 6(6):620-5. PubMed ID: 17030015
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Forestier-Rotes Querol syndrome].
    Muñoz del Castillo F; Bravo Rodríguez F; Jurado Ramos A; López Villarejo P
    An Otorrinolaringol Ibero Am; 2003; 30(5):525-32. PubMed ID: 14648932
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bone: Exploring factors responsible for bone formation in DISH.
    Mader R; Verlaan JJ
    Nat Rev Rheumatol; 2011 Dec; 8(1):10-2. PubMed ID: 22193856
    [No Abstract]   [Full Text] [Related]  

  • 73. Peridental mass in a patient with Forestier's/DISH.
    Boulman N; Rosner I; Slobodin G; Avshovich N; Feld J; Zeina AR; Rozenbaum M
    Rheumatology (Oxford); 2009 May; 48(5):482. PubMed ID: 19252197
    [No Abstract]   [Full Text] [Related]  

  • 74. Resolving the growth-promoting and metabolic effects of growth hormone: Differential regulation of GH-IGF-I system components.
    Norbeck LA; Kittilson JD; Sheridan MA
    Gen Comp Endocrinol; 2007 May; 151(3):332-41. PubMed ID: 17376444
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Forestier disease: a particular form of ossifying entesiopathy].
    Fournié A
    Presse Med; 1990 May; 19(18):844-5. PubMed ID: 2140177
    [No Abstract]   [Full Text] [Related]  

  • 76. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC; Dunger DB
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Type 2 diabetes mellitus and skeletal muscle metabolic function.
    Phielix E; Mensink M
    Physiol Behav; 2008 May; 94(2):252-8. PubMed ID: 18342897
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bone and entheseal targets for growth factors in diffuse idiopathic skeletal hyperostosis.
    Littlejohn GO
    Semin Arthritis Rheum; 2024 Oct; 68():152532. PubMed ID: 39146917
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Symptomatic sacroiliac involvement in Forestier disease. Efficacy of intra-articular corticotherapy].
    Chazerain P; Perrot S; Cariou D; Ziza JM
    Ann Med Interne (Paris); 1994; 145(2):147-8. PubMed ID: 8024180
    [No Abstract]   [Full Text] [Related]  

  • 80. [Drugs influencing bone metabolism in diabetic patients].
    Palicka V
    Vnitr Lek; 2009 Apr; 55(4):368-70. PubMed ID: 19449752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.